180 related articles for article (PubMed ID: 34867785)
1. Effects of Proton Pump Inhibitor Therapy,
Veysey-Smith R; Moore AR; Murugesan SV; Tiszlavicz L; Dockray GJ; Varro A; Pritchard DM
Front Endocrinol (Lausanne); 2021; 12():741887. PubMed ID: 34867785
[TBL] [Abstract][Full Text] [Related]
2. Effects of Proton Pump Inhibitor on the Distribution of Helicobacter pylori and Associated Gastritis in Patients with Gastric Atrophy.
Gong EJ; Kim DH; Ahn JY; Na HK; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Park Y; Kim MJ
Digestion; 2020; 101(3):279-286. PubMed ID: 31067538
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese.
Zhang Z; Sun Lp; Gong YH; Wang XG; Zhang M; Yuan Y
J Dig Dis; 2007 May; 8(2):72-6. PubMed ID: 17532818
[TBL] [Abstract][Full Text] [Related]
4. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
5. Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors.
Larkin CJ; Watson RGP ; Sloan JM; Stevenson M; Ardill JE; Buchanan D
Scand J Gastroenterol; 2000 Jun; 35(6):578-82. PubMed ID: 10912656
[TBL] [Abstract][Full Text] [Related]
6. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.
Parsons BN; Ijaz UZ; D'Amore R; Burkitt MD; Eccles R; Lenzi L; Duckworth CA; Moore AR; Tiszlavicz L; Varro A; Hall N; Pritchard DM
PLoS Pathog; 2017 Nov; 13(11):e1006653. PubMed ID: 29095917
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and helicobacter pylori-associated pathogenesis.
Hagiwara T; Mukaisho K; Nakayama T; Hattori T; Sugihara H
Asian Pac J Cancer Prev; 2015; 16(4):1315-9. PubMed ID: 25743791
[TBL] [Abstract][Full Text] [Related]
9. Antral Helicobacter pylori infection, hypergastrinemia and peptic ulcers: effect of eradicating the organism.
Park SM; Yoo BC; Lee HR; Yoon JH; Cha YJ
Korean J Intern Med; 1993 Jan; 8(1):19-24. PubMed ID: 8268142
[TBL] [Abstract][Full Text] [Related]
10. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
11. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
[TBL] [Abstract][Full Text] [Related]
12. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
13. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
el-Nujumi A; Williams C; Ardill JE; Oien K; McColl KE
Gut; 1998 Feb; 42(2):159-65. PubMed ID: 9536937
[TBL] [Abstract][Full Text] [Related]
14. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Wagner S; Haruma K; Gladziwa U; Soudah B; Gebel M; Bleck J; Schmidt H; Manns M
Am J Gastroenterol; 1994 Aug; 89(8):1211-8. PubMed ID: 8053437
[TBL] [Abstract][Full Text] [Related]
16. Gastrin and Helicobacter pylori in low-grade MALT lymphoma patients.
Ohashi S; Segawa K; Okamura S; Urano F; Kanamori S; Hosoi T; Ishikawa H; Kanamori A; Kitabatake S; Sano H; Kobayashi T; Maeda M
Scand J Gastroenterol; 2002 Mar; 37(3):279-86. PubMed ID: 11916189
[TBL] [Abstract][Full Text] [Related]
17. Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.
Haruma K; Kamada T; Manabe N; Suehiro M; Kawamoto H; Shiotani A
Digestion; 2018; 97(4):340-344. PubMed ID: 29587283
[TBL] [Abstract][Full Text] [Related]
18. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men.
Katelaris PH; Seow F; Lin BP; Napoli J; Ngu MC; Jones DB
Gut; 1993 Aug; 34(8):1032-7. PubMed ID: 8174948
[TBL] [Abstract][Full Text] [Related]
19. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
20. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
